A randomized controlled trial of smoking cessation treatment for young adult dual users of combustible and electronic cigarettes
对同时使用可燃烟和电子烟的年轻成人进行戒烟治疗的随机对照试验
基本信息
- 批准号:10292910
- 负责人:
- 金额:$ 10.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-15 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:AbstinenceAcuteAdultAdverse eventBehaviorCigarette SmokerElectronic cigaretteHealthLifeNicotineNicotine DependenceOutcomeParticipantPopulationPrevalencePublishingRandomizedRandomized Controlled TrialsResearchSmokeSmokerSmokingSmoking Cessation InterventionTestingText MessagingTobaccoUnited StatesVermontbasecigarette smokingcombustible cigaretteeffectiveness testingelectronic cigarette useelectronic cigarette userfollow-upmortalitynicotine replacementprimary outcomesmoking cessationyoung adult
项目摘要
Over 480,000 people die per year from combustible cigarette (CC) smoking related illness in the
United States. Young adults are particularly vulnerable to nicotine dependence and harm from tobacco.
The prevalence of electronic cigarette (EC) use has increased exponentially over the past decade and
is highest among young adults. ECs could substantially reduce harm for young adult smokers who
completely switch from CCs to ECs and remain abstinent from CCs. However, most who use ECs
continue to smoke CCs (i.e., dual users), which could perpetuate nicotine dependence and harm from
CC smoking. There are no empirically based treatments for dual users and it is unclear whether quitting
CCs only or quitting both CCs and ECs simultaneously is more effective to achieve long-term
abstinence from CCs. Nicotine replacement therapy (NRT) is an effective first-line smoking cessation
treatment for adult CC smokers but has never been tested among young adults or among dual users.
Given the strong evidence that smoking cessation early in life can completely avoid tobacco-related
mortality, there is a need to test effective smoking cessation treatment for young adult dual users.
The overarching aim of the proposed 2x2 factorial RCT is to test NRT with text message support for
two smoking cessation approaches among young adult dual users of CCs and ECs. Specifically, we
aim to 1) test the effectiveness of NRT for CC cessation among young adult dual users and 2) test
whether quitting CCs only versus quitting CCs and ECs simultaneously is more effective to achieve CC
abstinence. Participants (n=390) will be randomized to receive A) NRT plus text messages to quit CCs
only, B) NRT plus text messages to quit CCs and ECs simultaneously, C) text messages alone to quit
CCs only, or D) text messages alone to quit CCs and ECs simultaneously. Our primary outcome will be
CO-verified 7-day point-prevalence abstinence at the end of treatment (i.e., 3 months after
randomization).
Findings from our primary aims will directly inform smoking cessation treatment for young adult dual
users, a population that is particularly vulnerable to the harmful effects of nicotine addiction. This is
important given the current lack of published research on smoking cessation treatment for dual users or
NRT for young adults. As secondary aims, we will explore the interaction between NRT use versus no
use and quitting CCs only versus CCs and ECs simultaneously as well as change in nicotine
dependence, demand, and other smoking related outcomes among participants who fail to quit.
Broadly, findings will have applied implications for treating young adult dual users and scientific
implications regarding the effects of quitting one (CCs) versus two (CCs and ECs) nicotine products
simultaneously.
在美国,每年有超过480,000人死于与可燃香烟(CC)吸烟相关的疾病
美国的年轻人特别容易受到尼古丁依赖和烟草危害的影响。
电子烟(EC)的使用在过去十年中呈指数级增长,
在年轻人中最高。ECs可以大大减少年轻成年吸烟者的伤害,
完全从CC转换到EC,并保持对CC的禁欲。然而,大多数使用EC的人
继续抽吸CC(即,双重使用者),这可能会使尼古丁依赖和危害永久化,
CC吸烟目前还没有针对双重使用者的基于经验的治疗方法,
只有CC或同时退出CC和EC更有效地实现长期
戒CC。尼古丁替代疗法(NRT)是一种有效的一线戒烟方法
但从未在年轻人或双重使用者中进行过测试。
鉴于有强有力的证据表明,在生命早期戒烟可以完全避免与烟草有关的
死亡率,有必要测试有效的戒烟治疗的年轻成人双重用户。
拟议的2x2析因RCT的总体目标是测试NRT与文本消息支持,
两种戒烟方法在年轻成人的CC和EC双重用户。我们特别
目的是1)测试NRT在年轻成人双重使用者中停止CC的有效性,2)测试
是否仅退出CC或同时退出CC和EC更有效地实现CC
禁欲受试者(n=390)将随机接受A)NRT加短信以退出CC
仅限,B)NRT加短信同时退出CC和EC,C)仅短信退出
仅CC,或D)单独发送短信以同时退出CC和EC。我们的主要成果将是
治疗结束时经CO验证的7天时点戒烟率(即,后3个月
随机化)。
从我们的主要目标的结果将直接告知戒烟治疗的年轻成人双重
吸烟者是一个特别容易受到尼古丁成瘾有害影响的人群。这是
鉴于目前缺乏关于双重使用者戒烟治疗的已发表研究,这一点很重要,
NRT对于年轻人来说。作为次要目的,我们将探讨使用NRT与不使用NRT之间的相互作用。
仅使用和戒烟CC与同时使用CC和EC以及尼古丁的变化
依赖,需求和其他吸烟相关的结果在参与者谁未能戒烟。
从广义上讲,研究结果将对治疗年轻成人双重使用者和科学
关于戒烟一种(CC)与两种(CC和EC)尼古丁产品效果的影响
同步
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Elias Mushabac Klemperer其他文献
Elias Mushabac Klemperer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Elias Mushabac Klemperer', 18)}}的其他基金
A randomized controlled trial of smoking cessation treatment for young adult dual users of combustible and electronic cigarettes
对同时使用可燃烟和电子烟的年轻成人进行戒烟治疗的随机对照试验
- 批准号:
10285534 - 财政年份:2020
- 资助金额:
$ 10.79万 - 项目类别:
A randomized controlled trial of smoking cessation treatment for young adult dual users of combustible and electronic cigarettes
对同时使用可燃烟和电子烟的年轻成人进行戒烟治疗的随机对照试验
- 批准号:
10491323 - 财政年份:2013
- 资助金额:
$ 10.79万 - 项目类别:
相似海外基金
Un/kindness, shame & resistance: the care of inpatients in NHS adult acute mental health units and how it might be improved
Un/善良,羞耻
- 批准号:
2885806 - 财政年份:2023
- 资助金额:
$ 10.79万 - 项目类别:
Studentship
Post-Acute Care Transitions for Older Adult Medicare Beneficiaries with Serious Mental Illness
患有严重精神疾病的老年医疗保险受益人的急性后护理过渡
- 批准号:
10772386 - 财政年份:2023
- 资助金额:
$ 10.79万 - 项目类别:
Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)
通过 CAR-T 细胞疗法为加拿大护理标准铺平道路:CD19 CAR-T 治疗复发/难治性成人急性淋巴细胞白血病的 II 期试验 (CLIC-01A)
- 批准号:
474619 - 财政年份:2022
- 资助金额:
$ 10.79万 - 项目类别:
Operating Grants
Investigating the impact acute inhalation of cannabis with a high content of delta-9-tetrahydrocannabinol has on myelination and microglia in adult and aged mice
研究急性吸入高含量 delta-9-四氢大麻酚的大麻对成年和老年小鼠髓鞘形成和小胶质细胞的影响
- 批准号:
485965 - 财政年份:2022
- 资助金额:
$ 10.79万 - 项目类别:
Studentship Programs
Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)
通过 CAR-T 细胞疗法为加拿大护理标准铺平道路:CD19 CAR-T 治疗复发/难治性成人急性淋巴细胞白血病的 II 期试验 (CLIC-01A)
- 批准号:
466358 - 财政年份:2022
- 资助金额:
$ 10.79万 - 项目类别:
Operating Grants
Metabolomics for prediction of cisplatin mediated acute kidney injury: a Canadian multi-centre adult and pediatric study
预测顺铂介导的急性肾损伤的代谢组学:加拿大多中心成人和儿童研究
- 批准号:
402040 - 财政年份:2019
- 资助金额:
$ 10.79万 - 项目类别:
Operating Grants
Study of pathogenic mechanism of age-dependent chromosome translocation in adult acute lymphoblastic leukemia
成人急性淋巴细胞白血病年龄依赖性染色体易位发病机制研究
- 批准号:
18K16103 - 财政年份:2018
- 资助金额:
$ 10.79万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Causal effect of time-varying driving pressures on mortality in mechanically ventilated, adult patients with acute respiratory distress syndrome
时变驱动压力对机械通气成年急性呼吸窘迫综合征患者死亡率的因果影响
- 批准号:
377313 - 财政年份:2017
- 资助金额:
$ 10.79万 - 项目类别:
Studentship Programs
Role of SETBP1 in adult Ph+ acute lymphoblastic leukemia
SETBP1 在成人 Ph 急性淋巴细胞白血病中的作用
- 批准号:
9315111 - 财政年份:2016
- 资助金额:
$ 10.79万 - 项目类别:
Acute Inhibition of Adult-born Granule Cells and its Effect on Antidepressant Act
成体颗粒细胞的急性抑制及其抗抑郁作用
- 批准号:
8734273 - 财政年份:2013
- 资助金额:
$ 10.79万 - 项目类别: